Repligen Corp (RGEN)

176.73 +4.41 (+2.56%) USD  |  NASDAQ  |  Mar 21, 09:48
More

Repligen News

News

Headline
Wire
Time (ET)
Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor Forum
Yahoo
03/14 07:30
UBS Adjusts Repligen's Price Target to $210 From $215, Maintains Buy Rating
MT Newswires
02/24 11:50
Repligen Corporation (NASDAQ:RGEN) Q4 2022 Earnings Call Transcript
Yahoo
02/23 18:28
Repligen's (RGEN) Q4 Earnings and Revenues Beat Estimates
Yahoo
02/23 13:41
KeyBanc Adjusts Price Target on Repligen to $240 From $260, Keeps Overweight Rating
MT Newswires
02/23 09:45
Repligen Full Year 2022 Earnings: EPS Beats Expectations
Yahoo
02/23 05:54
Repligen (RGEN) Q4 Earnings and Revenues Surpass Estimates
Yahoo
02/22 08:55
Repligen Q4 Adjusted Earnings Drops, Revenue Gains; Issues 2023 Outlook
MT Newswires
02/22 08:03
-- Earnings Flash (RGEN) REPLIGEN CORPORATION Posts Q4 Revenue $186.8M, vs. Street Est of $184.4M
MT Newswires
02/22 07:32
-- Earnings Flash (RGEN) REPLIGEN CORPORATION Reports Q4 EPS $0.68, vs. Street Est of $0.58
MT Newswires
02/22 07:31
Repligen Reports Fourth Quarter and Full Year 2022 Financial Results
Yahoo
02/22 07:30
Why Repligen Corporation (NASDAQ:RGEN) Could Be Worth Watching
Yahoo
02/20 06:34
Insider Sell: Repligen
MT Newswires
02/17 17:02
Repligen Appoints Martin D. Madaus to Board of Directors
Globe Newswire
02/09 07:30
Repligen to Report Fourth Quarter and Full Year 2022 Financial Results
Globe Newswire
02/08 07:30
--RBC Cuts Price Target on Repligen to $179 From $190, Maintains Sector Perform Rating
MT Newswires
01/30 07:57
Repligen (NASDAQ:RGEN) stock performs better than its underlying earnings growth over last five years
Yahoo
01/21 09:51
Moderna (MRNA) Soars 3.3%: Is Further Upside Left in the Stock?
Yahoo
01/19 03:10
Do Options Traders Know Something About Repligen (RGEN) Stock We Don't?
Yahoo
01/13 08:30
Why Shares of Repligen Rose This Week
Yahoo
01/12 17:00
HZNP vs. RGEN: Which Stock Is the Better Value Option?
Yahoo
01/12 11:40
SVB Securities Adjusts Repligen's Price Target to $200 From $230, Keeps Outperform Rating
MT Newswires
01/06 10:52
Repligen Corporation to Present at 41st Annual J.P. Morgan Healthcare Conference
Globe Newswire
01/03 07:30
If EPS Growth Is Important To You, Repligen (NASDAQ:RGEN) Presents An Opportunity
Yahoo
12/21 10:56
Deutsche Bank Initiates Coverage on Repligen With Hold Rating, $180 Price Target
MT Newswires
12/14 13:08
RBC Initiates Repligen at Sector Perform, Sets Price Target at $190, Sees 'Growth in Attractive End Markets Fully Priced In'
MT Newswires
12/07 08:16
Insider Sell: Repligen
MT Newswires
11/14 17:46
Repligen Corporation to Present at Upcoming Investor Conferences
Globe Newswire
11/08 07:30
--UBS Adjusts Repligen Price Target to $215 From $275, Maintains Buy Rating
MT Newswires
11/02 10:28
Repligen, Purolite Expand Long-Term Supply Deal
MT Newswires
11/01 11:21
Repligen Q3 Adjusted EPS Falls, Revenue Rises; Revises Full-Year Guidance
MT Newswires
11/01 10:02
-- Earnings Flash (RGEN) REPLIGEN CORPORATION Reports Q3 Revenue $200.7M, vs. Street Est of $191.5M
MT Newswires
11/01 07:34
-- Earnings Flash (RGEN) REPLIGEN CORPORATION Reports Q3 EPS $0.77, vs. Street Est of $0.68
MT Newswires
11/01 07:34
Repligen Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Financial Guidance
Globe Newswire
11/01 07:30
Repligen Extends and Expands Long-Term Supply Agreement with Purolite for Affinity Ligands
Globe Newswire
11/01 07:00
Repligen to Report Third Quarter 2022 Financial Results
Globe Newswire
10/12 07:30
Thinking about trading options or stock in Laredo Petroleum, Repligen, Tesla, Amazon, or Advanced Micro Devices?
PR Newswire
10/04 09:35
Repligen Says It Expands Process Analytics Portfolio With DRS Daylight Solutions Deal
MT Newswires
09/19 17:24
Repligen Expands Process Analytics Portfolio with DRS Daylight Solutions Agreement
Globe Newswire
09/19 16:01
Repligen To Host Investor Day 2022
Globe Newswire
08/24 07:30
Insider Sell: Repligen
MT Newswires
08/17 16:47
Repligen gains after report of rejected takeover offer
SA Breaking News
08/11 14:25
Insider Sell: Repligen
MT Newswires
08/05 16:31
--UBS Adjusts Repligen Price Target to $275 From $213, Maintains Buy Rating
MT Newswires
08/05 11:29
Insider Sell: Repligen
MT Newswires
08/04 16:42
--Stephens Adjusts Repligen's Price Target to $275 from $220, Keeps Overweight Rating
MT Newswires
08/03 10:20
--SVB Securities Adjusts Repligen's Price Target to $250 From $220, Keeps Outperform Rating
MT Newswires
08/03 05:27
--KeyBanc Adjusts Repligen's Price Target to $260 From $245, Reiterates Overweight Rating
MT Newswires
08/03 05:27
Insider Sell: Repligen
MT Newswires
08/02 17:35
Repligen's Shares Surge After Q2 Results Beat Estimate
MT Newswires
08/02 13:01
Repligen surges 11% as it raises fiscal 2022 financial guidance
SA Breaking News
08/02 11:23
Repligen's Q2 Adjusted Earnings, Revenue Rise
MT Newswires
08/02 08:08
-- Earnings Flash (RGEN) REPLIGEN CORPORATION Posts Q2 Revenue $207.6M
MT Newswires
08/02 07:31
-- Earnings Flash (RGEN) REPLIGEN CORPORATION Posts Q2 EPS $0.91
MT Newswires
08/02 07:30
Repligen Reports Second Quarter 2022 Financial Results and Raises Full Year 2022 Financial Guidance
Globe Newswire
08/02 07:30
Notable earnings before Tuesday's open
SA Breaking News
08/01 10:59
Insider Sell: Repligen
MT Newswires
07/22 16:32
1Life, Tabula Rasa top healthcare gainers; LumiraDx, Verve lead losers' pack
SA Breaking News
07/21 10:05
--UBS Initiates Coverage on Repligen With Buy Rating, $213 Price Target
MT Newswires
07/20 11:32
Repligen attracts initial bull rating at UBS Group on long-term growth prospects
SA Breaking News
07/20 11:18
Repligen to Report Second Quarter 2022 Financial Results
Globe Newswire
07/19 07:30
Insider Sell: Repligen
MT Newswires
05/26 17:29
Repligen Appoints Dr. Konstantin Konstantinov to Board of Directors
Globe Newswire
05/26 16:30
--Craig-Hallum Adjusts Repligen's Price Target to $274 From $286, Reiterates Buy Rating
MT Newswires
04/28 09:10
--KeyBanc Adjusts Repligen's Price Target to $245 From $335, Keeps Overweight Rating
MT Newswires
04/28 09:00
Sector Update: Health Care Stocks Posting Small Gains Ahead of Wednesday's Close
MT Newswires
04/27 15:10
Update: Repligen Reports Higher Q1 Adjusted Earnings, Revenue; Reduces 2022 Guidance -- Shares Rise
MT Newswires
04/27 13:36
Sector Update: Health Care Stocks Carried Higher in Wednesday Trade
MT Newswires
04/27 13:06
Nutex, Repligen top healthcare gainers; Molecular Partners, Agile lead losers' pack
SA Breaking News
04/27 10:01
Repligen Reports Higher Q1 Adjusted Earnings, Revenue; Reduces 2022 Guidance
MT Newswires
04/27 08:08
-- Earnings Flash (RGEN) REPLIGEN CORPORATION Reports Q1 Revenue $206.4M, vs. Street Est of $185.5M
MT Newswires
04/27 07:36
-- Earnings Flash (RGEN) REPLIGEN CORPORATION Reports Q1 EPS $0.92, vs. Street Est of $0.72
MT Newswires
04/27 07:36
Repligen Reports First Quarter 2022 Financial Results and Updates Full Year 2022 Financial Guidance
Globe Newswire
04/27 07:30
Repligen to Report First Quarter 2022 Financial Results
Globe Newswire
04/13 07:30
Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor Forum
Globe Newswire
03/18 07:30
Thinking about trading options or stock in Repligen, Zendesk, United Airlines, Dollar Tree, or BioNTech?
PR Newswire
03/15 09:31
SVB Leerink Adjusts Repligen's Price Target to $250 from $275, Maintains Outperform Rating
MT Newswires
02/18 07:42
Repligen Reports Higher Q4 Adjusted Profit, Revenue; Provides In-Line 2022 Outlook
MT Newswires
02/17 07:53
-- Earnings Flash (RGEN) REPLIGEN CORPORATION Posts Q4 EPS $0.81, vs. Street Est of $0.65
MT Newswires
02/17 07:31
-- Earnings Flash (RGEN) REPLIGEN CORPORATION Posts Q4 Revenue $186.5M, vs. Street Est of $178.3M
MT Newswires
02/17 07:31
Repligen Reports Fourth Quarter and Full Year 2021 Financial Results
Globe Newswire
02/17 07:30
Repligen Q4 2021 Earnings Preview
SA Breaking News
02/16 12:31
Repligen Launches AAV Affinity Resins for Gene Therapy Purification
Globe Newswire
02/15 07:30
Repligen Corporation to Present at 11th Annual SVB Leerink Healthcare Conference
Globe Newswire
02/11 07:30
Repligen Corporation to Present at 40th Annual J.P. Morgan Healthcare Conference
Globe Newswire
12/30 07:30
Insider Sell: Repligen
MT Newswires
11/22 07:56
Insider Sell: Repligen
MT Newswires
11/15 07:18
Insider Sell: Repligen
MT Newswires
11/04 17:53
Insider Sell: Repligen
MT Newswires
11/02 17:20
--SVB Leerink Adjusts Price Target on Repligen to $325 from $260, Keeps Outperform Rating
MT Newswires
10/29 10:26
Repligen shares rise after Q3 earnings beat, FY forecast raise
SA Breaking News
10/28 10:21
Repligen Q3 Adjusted Earnings, Revenue Jump; Company Lifts 2021 Outlook
MT Newswires
10/28 08:54
-- Earnings Flash (RGEN) REPLIGEN CORPORATION Reports Q3 EPS $0.78, vs. Street Est of $0.64
MT Newswires
10/28 07:32
-- Earnings Flash (RGEN) REPLIGEN CORPORATION Posts Q3 Revenue $178.2M, vs. Street Est of $164M
MT Newswires
10/28 07:32
Repligen Reports Third Quarter 2021 Financial Results and Updates Full Year 2021 Financial Guidance
Globe Newswire
10/28 07:30
Notable earnings before Thursday's open
SA Breaking News
10/27 10:40
Exane BNP Paribas Starts Repligen at Outperform with $330 Price Target
MT Newswires
10/14 09:25
Repligen to Report Third Quarter 2021 Financial Results
Globe Newswire
10/14 07:30
Craig Hallum Adjusts Repligen PT to $368 From $258, Maintains Buy Rating
MT Newswires
09/27 11:11
KeyBanc Raises Price Target on Repligen to $335 From $255, Keeps Overweight Rating
MT Newswires
09/17 07:25
Repligen to Acquire Chromatography Developer Avitide in $150 Million Cash-And-Stock Deal
MT Newswires
09/16 08:26
Repligen Announces Agreement to Acquire Avitide Inc.
Globe Newswire
09/16 07:40
Insider Sell: Repligen
MT Newswires
09/14 08:08
Repligen and Navigo GmbH Announce Launch of Industry-First Protein A Ligand for Purification of pH Sensitive Antibodies
Globe Newswire
09/09 07:30
Insider Sell: Repligen
MT Newswires
09/02 16:45
Stephens Adjusts Repligen's Price Target to $290 From $255, Maintains Overweight Rating
MT Newswires
08/20 11:15
Thinking about trading options or stock in Sonos, MicroStrategy, eBay, Pfizer, or Repligen Corp?
PR Newswire
08/16 09:31
--William O'Neil Starts Repligen at Buy
MT Newswires
07/29 11:24
Repligen Reports Higher Q2 Earnings, Revenue From 2020 Levels, Raises Full-Year Outlook
MT Newswires
07/27 08:35
Repligen EPS beats by $0.27, beats on revenue
SA Breaking News
07/27 07:34
-- Earnings Flash (RGEN) REPLIGEN CORPORATION Posts Q2 EPS $0.79, vs. Street Est of $0.52
MT Newswires
07/27 07:30
-- Earnings Flash (RGEN) REPLIGEN CORPORATION Reports Q2 Revenue $163M, vs. Street Est of $144.2M
MT Newswires
07/27 07:30
Repligen Reports Second Quarter 2021 Financial Results and Updates Full Year 2021 Financial Guidance
Globe Newswire
07/27 07:30
Notable earnings before Tuesday's open
SA Breaking News
07/26 10:08
Repligen To Buy Polymem For Undisclosed Sum
MT Newswires
06/22 06:54
Repligen inks an agreement to acquire Polymem S.A.
SA Breaking News
06/22 06:44
Repligen Corporation Announces Agreement to Acquire Polymem S.A.
Globe Newswire
06/22 06:30
Repligen Corporation to Present at Upcoming Investor Conferences
Globe Newswire
05/25 07:30
--HC Wainwright Adjusts Repligen's Price Target to $240 From $225, Maintains Buy Rating
MT Newswires
05/05 07:35
Repligen Posts Rise in Q1 Adjusted Profit, Revenue; Amends 2021 Forecasts
MT Newswires
05/04 09:26
Repligen shares rise on strong first-quarter results, FY forecast raise
SA Breaking News
05/04 08:20
Repligen EPS beats by $0.25, beats on revenue; increases FY 2021 guidance
SA Breaking News
05/04 07:36
-- Earnings Flash (RGEN) REPLIGEN CORPORATION Reports Q1 EPS $0.68, vs. Street Est of $0.40
MT Newswires
05/04 07:31
-- Earnings Flash (RGEN) REPLIGEN CORPORATION Posts Q1 Revenue $142.8M, vs. Street Est of $117M
MT Newswires
05/04 07:31
Repligen Reports First Quarter 2021 Financial Results and Updates Full Year 2021 Financial Guidance
Globe Newswire
05/04 07:30
Repligen Q1 Earnings Preview
SA Breaking News
05/03 13:23
Notable earnings before Tuesday's open
SA Breaking News
05/03 13:04
Repligen to Report First Quarter 2021 Financial Results
Globe Newswire
04/20 07:30
Analyst Actions: HC Wainwright Adjusts Repligen's Price Target to $225 From $168, Maintains Buy Rating
MT Newswires
04/12 06:35
Watch these most and least crowded stocks for big post-earnings moves
SA Breaking News
03/25 11:41
Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor Forum
Globe Newswire
03/17 07:30
Repligen Corporation to Present at Barclays Global Healthcare Conference
Globe Newswire
03/03 07:30
--Analyst Actions: SVB Leerink Adjusts Repligen's Price Target to $250 From $220, Keeps Outperform Rating
MT Newswires
02/25 10:20
Repligen Reports Growth in Q4 Adjusted Earnings, Revenue; Issues 2021 Targets
MT Newswires
02/24 08:40
-- Earnings Flash (RGEN) REPLIGEN CORPORATION Reports Q4 EPS $0.52, vs. Street Est of $0.31
MT Newswires
02/24 07:32
-- Earnings Flash (RGEN) REPLIGEN CORPORATION Reports Q4 Revenue $108.6M, vs. Street Est of $93.9M
MT Newswires
02/24 07:32
Repligen EPS beats by $0.21, beats on revenue
SA Breaking News
02/24 07:31
Repligen Reports Fourth Quarter and Full Year 2020 Financial Results
Globe Newswire
02/24 07:30
Notable earnings before Wednesday's open
SA Breaking News
02/23 11:45
Repligen Q4 Earnings Preview
SA Breaking News
02/23 11:29
Repligen Corporation to Present at 10th Annual SVB Leerink Healthcare Conference
Globe Newswire
02/22 07:30
Repligen to Report Fourth Quarter and Full Year 2020 Financial Results
Globe Newswire
02/11 15:00
Repligen, Navigo Launches COVID-19 Vaccine Purification Resin
MT Newswires
02/08 10:21
Repligen and Navigo announce launch of affinity resin for COVID-19 vaccine purification
SA Breaking News
02/08 07:59
Repligen and Navigo Proteins Announce the Launch of an Affinity Resin for the Purification of COVID-19 Vaccines
Globe Newswire
02/08 07:36
Repligen Corporation to Present at 39th Annual J.P. Morgan Healthcare Conference
Globe Newswire
01/04 13:00
Repligen Corporation Announces Closing of Public Offering of $312.2 Million, Including Full Exercise of Underwriters’ Option
Globe Newswire
12/10 16:17
EC Mergers & Acquisitions advised ARTeSYN on its Sale to Repligen
PR Newswire
12/08 12:20
Repligen Prices $271.5 Million Public Offering
MT Newswires
12/08 03:09
Repligen prices equity offering at $181
SA Breaking News
12/07 23:30
Repligen Corporation Prices Public Offering of Shares of Common Stock
Globe Newswire
12/07 21:40
Repligen announces proposed public offering
SA Breaking News
12/07 11:09
Repligen Corporation Announces Proposed Public Offering of Shares of Common Stock
Globe Newswire
12/07 07:21
--Analyst Actions: KeyBanc Starts Repligen at Overweight with $241 Price Target
MT Newswires
11/10 07:47
Should you invest in Advanced Micro Devices, Uber, Halozyme Therapeutics, Tilray, or Repligen Corp?
PR Newswire
11/06 10:55
Repligen EPS beats by $0.11, beats on revenue
SA Breaking News
11/05 07:36
-- Earnings Flash (RGEN) REPLIGEN CORPORATION Posts Q3 EPS $0.40, vs. Street Est of $0.28
MT Newswires
11/05 07:32
-- Earnings Flash (RGEN) REPLIGEN CORPORATION Reports Q3 Revenue $94.1M, vs. Street Est of $86.4M
MT Newswires
11/05 07:32
Repligen Reports Third Quarter 2020 Financial Results and Updates Full Year 2020 Financial Guidance
Globe Newswire
11/05 07:30
Repligen Q3 Earnings Preview
SA Breaking News
11/04 12:04
Repligen Agrees To Buy ARTeSYN Biosolutions
MT Newswires
10/27 17:19
Repligen Corporation Announces Agreement to Acquire Bioprocess Systems Innovator ARTeSYN Biosolutions and Completes Acquisition of Non-Metallic Solutions
Globe Newswire
10/27 16:15
Repligen to Report Third Quarter 2020 Financial Results
Globe Newswire
10/22 07:30
Repligen, Navigo Proteins to Scale up Manufacturing of New Purification Product for COVID-19 Vaccines
MT Newswires
10/01 10:07
Repligen and Navigo develop molecule for purification of COVID-19 vaccines
SA Breaking News
10/01 06:46
Repligen and Navigo Proteins Announce Achievement of Key Milestone in Developing an Affinity Resin for the Purification of COVID-19 Vaccines
Globe Newswire
10/01 06:30
Analyst Actions: HC Wainwright Lifts Repligen's Price Target to $168 From $151, Keeps at Buy
MT Newswires
08/24 07:23
Correction: Regeneron Pharmaceuticals, Not Repligen, BLA Accepted by FDA for Priority Review for Genetic Bad Cholesterol Therapy
MT Newswires
08/12 07:58
Repligen Says FDA Accepted BLA for Priority Review for Drug Candidate for Genetic Disease Associated With Bad Cholesterol
MT Newswires
08/12 07:37
Repligen Climbs on Higher Q2 Adj. EPS, Revenue; Revises 2020 Guidance
MT Newswires
07/30 11:16
-- Earnings Flash (RGEN) REPLIGEN CORP Reports Q2 Revenue $87.462M, vs. Street Est of $78.4M
MT Newswires
07/30 07:36
Repligen EPS beats by $0.14, beats on revenue
SA Breaking News
07/30 07:33
Repligen Reports Second Quarter 2020 Financial Results and Updates Full Year 2020 Financial Guidance
Globe Newswire
07/30 07:30
Repligen Q2 Earnings Preview
SA Breaking News
07/29 14:00
Notable earnings before Thursday's open
SA Breaking News
07/29 12:32
Repligen to Report Second Quarter 2020 Financial Results
Globe Newswire
07/15 07:30
Analyst Actions: HC Wainwright Raises Repligen's Price Target to $151 From $143, Reiterates Buy Rating
MT Newswires
06/30 10:50
Repligen to buy engineered molding technology firm
SA Breaking News
06/29 12:15
Repligen to Buy Engineered Molding Technology for Undisclosed Sum
MT Newswires
06/29 08:09
Repligen Announces Agreement to Acquire Engineered Molding Technology
Globe Newswire
06/29 07:30
Repligen Appoints Carrie Eglinton Manner to Board of Directors
Globe Newswire
06/15 07:30
Analyst Actions: Stifel Nicolaus Lifts Repligen's Price Target to $150 From $135, Reiterates Buy Rating
MT Newswires
05/27 10:30
--Analyst Actions: SVB Leerink Lifts Repligen's Price Target to $150 From $115, Keeps Outperform Rating
MT Newswires
05/07 10:33
--Analyst Actions: Janney Raises Repligen's Fair Value Estimate to $137 From $119 After Q1 'Top-to-Bottom Beat,' Reiterates Buy Rating
MT Newswires
05/06 10:37
Repligen Earnings, Revenue Rise; Increases 2020 Guidance; Shares Gain
MT Newswires
05/06 09:42
Repligen Reports First Quarter 2020 Financial Results and Updates Full Year 2020 Financial Guidance
Globe Newswire
05/06 07:30
Repligen to Report First Quarter 2020 Financial Results
Globe Newswire
04/22 07:30
Repligen Appoints Rohin Mhatre, Ph.D. to Board of Directors
Globe Newswire
02/27 07:30
--Analyst Actions: Stifel Nicolaus Lifts Repligen's Price Target to $116 From $105, Reiterates Buy Rating
MT Newswires
02/21 12:28
--Analyst Actions: Stephens Raises Repligen's Price Target to $114 From $112, Reiterates Overweight Rating
MT Newswires
02/21 10:05
Repligen Q4 2019 Results Top Street Forecasts; Shares Fall 5% Pre-Bell
MT Newswires
02/20 08:45
Repligen slips 5% premarket after Q4 earnings
SA Breaking News
02/20 08:22
Repligen EPS misses by $0.01, beats on revenue
SA Breaking News
02/20 07:31
Repligen Reports Fourth Quarter and Full Year 2019 Financial Results
Globe Newswire
02/20 07:30
Repligen to Present at the 38th Annual J.P. Morgan Healthcare Conference
Globe Newswire
01/07 07:30
Analyst Actions: Stifel Nicolaus Initiates Coverage on Repligen With Buy Rating, $105 Price Target
MT Newswires
11/15 07:36
Analyst Actions: First Analysis Upgrades Repligen to Strong Buy From Outperform, Lifts PT to $110 From $107
MT Newswires
11/01 11:56
Repligen Q3 Results Beat Estimates, Raises 2019 Guidance
MT Newswires
10/31 08:43
Repligen EPS misses by $0.03, beats on revenue
SA Breaking News
10/31 07:36
Repligen Reports Third Quarter 2019 Financial Results and Updates Full Year 2019 Financial Guidance
Globe Newswire
10/31 07:30
Repligen to Report Third Quarter 2019 Financial Results
Globe Newswire
10/23 10:29
Analyst Actions: SVB Leerink Initiates Coverage on Repligen With Outperform Rating, $100 Price Target
MT Newswires
10/15 13:14
Sector Update: Health Care Stocks Decline
MT Newswires
09/09 15:04
Sector Update: Health Care Stocks Weighing on Broader Markets
MT Newswires
09/09 13:56
Healthcare - Top 5 Gainers / Losers
SA Breaking News
09/09 11:02
S&P Dow Jones Indices Announces Nine Companies Set to Join S&P MidCap 400; Ten Companies to Join S&P SmallCap 600
PR Newswire
09/06 18:00
Rebalance moves companies among MidCap, SmallCap indexes
SA Breaking News
09/06 17:47
Analyst Actions: First Analysis Lifts Repligen's Price Target to $107 From $95, Maintains Outperform Rating
MT Newswires
08/28 07:50
Analyst Actions: Stephens Resumes Coverage on Repligen With Overweight Rating, $110 Price Target
MT Newswires
08/23 12:02
Stephens sees 48% upside in Cerus in premarket analyst action
SA Breaking News
08/23 07:17
Repligen Q2 Tops Estimates on EPS, Revenue; Increases Full-Year Guidance
MT Newswires
08/01 14:47
Repligen EPS misses by $0.01, beats on revenue
SA Breaking News
08/01 07:34
Repligen Reports Second Quarter 2019 Financial Results and Updates Full Year 2019 Financial Guidance
Globe Newswire
08/01 07:30
Repligen to Report Second Quarter 2019 Financial Results
Globe Newswire
07/23 16:01
Analyst Actions: HC Wainwright Upgrades Repligen to Buy From Neutral With $110 PT
MT Newswires
07/22 10:26
Sell-siders bullish on BridgeBio in premarket analyst action
SA Breaking News
07/22 07:36
Repligen Raises $130.7 Mln From Shares Offering, $278.4 Mln From Notes Offering
MT Newswires
07/22 06:00
Repligen Corporation Announces Closing of Public Offerings of $138.1 Million of Common Stock and $287.5 Million of 0.375% Convertible Senior Notes due 2024, Including Full Exercise of Underwriters’ Options
Globe Newswire
07/19 19:42
Repligen prices stock and notes offering
SA Breaking News
07/17 06:39
Repligen to Raise $370 Mln in Offerings of Common Stock, Notes
MT Newswires
07/17 03:37
Repligen Corporation Announces Pricing of Public Offerings of $120 million of Common Stock and $250 million of 0.375% Convertible Senior Notes due 2024
Globe Newswire
07/17 00:14
MT Newswires After-Hours News Movers
MT Newswires
07/15 17:47
SQM, JBHT and ARW among after hour movers
SA Breaking News
07/15 17:44
Repligen launches $350M capital raise; shares down 3% after hours
SA Breaking News
07/15 16:08
Repligen Plans to Sell $100 mln Shares, $250 Mln Convertible Notes - Stock Drops Near 5% After-Hours
MT Newswires
07/15 16:08
Repligen Corporation Announces Proposed Public Offerings of $100 million of Common Stock and $250 million of Convertible Senior Notes
Globe Newswire
07/15 16:02
Regeneron, Sanofi Win FDA Ok of Dupixent for Chronic Rhinosinusitis With Nasal Polyposis
MT Newswires
06/26 14:22
Repligen to Present at Jefferies 2019 Healthcare Conference
Globe Newswire
06/04 10:03
Repligen beats by $0.03, beats on revenue
SA Breaking News
05/09 07:35
Repligen Reports First Quarter 2019 Financial Results and Updates Full Year 2019 Financial Guidance
Globe Newswire
05/09 07:30
Repligen to Report First Quarter 2019 Financial Results
Globe Newswire
05/02 14:20
Close Update: Stocks Tumble After Fed Disappoints Investors Sending S&P 500 Off Record High
MT Newswires
05/01 16:30
Mid-Day Update: Apple Helps Boost US Stocks Ahead of Fed Decision Wednesday Afternoon
MT Newswires
05/01 12:45
SSNC and PBI among premarket losers
SA Breaking News
05/01 09:19
Wall Street Sees Upbeat Open Ahead of Fed's Rate Decision
MT Newswires
05/01 08:57
Repligen prices equity offering; shares down 2% premarket
SA Breaking News
05/01 07:15
Repligen Prices Public Share Offering at $64 Apiece
MT Newswires
05/01 05:43
Repligen Corporation Prices Public Offering of Shares of Common Stock
Globe Newswire
04/30 19:36
MTNewswires After-Hours News Movers
MT Newswires
04/29 17:56
Repligen Offers $175 Mln in Shares
MT Newswires
04/29 17:20
Repligen Corporation Announces Proposed Public Offering of Shares of Common Stock
Globe Newswire
04/29 16:19
Close Update: S&P 500, Nasdaq Set Closing High Records as Stocks End Week With Gains
MT Newswires
04/26 16:34
Sector Update: Health Care Stocks Outpace Most Other Sectors Again
MT Newswires
04/26 16:02
Sector Update: Health Care Stocks Rising Friday Afternoon
MT Newswires
04/26 14:57
INTC, RGEN, BGG and HELE among midday movers
SA Breaking News
04/26 12:53
--Analyst Actions: Janney Raises Repligen's Fair Value Estimate to $85, Reiterates Buy Rating
MT Newswires
04/26 11:08
Repligen Guides Q1 EPS, Sales Above Estimates; Stock Surges on $240 Million Acquisition of C Technologies
MT Newswires
04/26 11:05
Aratana Therapeutics and Repligen among healthcare gainers; BioTelemetry and Immunic among losers
SA Breaking News
04/26 11:01
Repligen announces acquisition of C Technologies for $240M, and preliminary Q1 results
SA Breaking News
04/26 09:28
Repligen Corporation Announces Agreement to Acquire Process Analytics Innovator C Technologies and Reports Preliminary First Quarter 2019 Financial Results
Globe Newswire
04/26 07:30